Cargando…

Retrospective review of nicotine exposures in California from 2012 to 2018 and analysis of the impacts of e-cigarette regulations

OBJECTIVES: To review the association between US e-cigarette regulations and the number of reported nicotine exposures, and identify higher-risk products DESIGN: Retrospective review of de-identified medical records. SETTING: California PARTICIPANTS: Cases reported to California Poison Control Syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Driller, Gabrielle, Plasencia, Emily, Apollonio, Dorie E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929887/
https://www.ncbi.nlm.nih.gov/pubmed/33653751
http://dx.doi.org/10.1136/bmjopen-2020-043133
_version_ 1783659998320001024
author Driller, Gabrielle
Plasencia, Emily
Apollonio, Dorie E
author_facet Driller, Gabrielle
Plasencia, Emily
Apollonio, Dorie E
author_sort Driller, Gabrielle
collection PubMed
description OBJECTIVES: To review the association between US e-cigarette regulations and the number of reported nicotine exposures, and identify higher-risk products DESIGN: Retrospective review of de-identified medical records. SETTING: California PARTICIPANTS: Cases reported to California Poison Control System in 2012–2018. PRIMARY AND SECONDARY OUTCOME MEASURES: Suspected nicotine toxicity; route of exposure and product characteristics. RESULTS: We examined 5277 exposures, of which 3033 involved combustible cigarettes, 1489 involved e-cigarettes and 818 involved other substances (ie, chewing tobacco, nicotine patches, nicotine lozenges, hookah, etc). Implementation of the Child Nicotine Poisoning Prevention Act of 2015 was not significantly associated with reduced exposures. Exposures for e-cigarettes increased significantly after the 2017 Food and Drug Administration Compliance Policy (p=0.003, coefficient (coeff)=0.61). Total exposures for all tobacco and nicotine products also increased significantly after the policy change (p=0.01, coeff=1.26). Nicotine exposure outcomes classified as being of minor and moderate severity increased significantly after implementation of the 2017 Compliance Policy (p=0.004, coeff=0.54 and p=0.002, coeff=0.56, respectively). Ingestion was the most common route of exposure (87.7%), followed by inhalation (8.1%), dermal (6.5%), ocular (2.1%) and other (intranasal, rectal, sublingual and unknown) routes (0.2%); some cases reported multiple routes of exposure. Exposure cases involving e-cigarettes fell into three problem categories: product design, labelling and the appeal of flavours. CONCLUSIONS: Our analysis found that despite previous studies suggesting that the Child Nicotine Poisoning Prevention Act appeared to have reduced exposures for e-cigarettes, there was no significant change in exposures after its implementation. In contrast, there was a 30% increase in California e-cigarette exposures following the 2017 Compliance Policy. We conclude that current regulations are insufficient to reduce nicotine toxicities due to e-cigarette use.
format Online
Article
Text
id pubmed-7929887
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-79298872021-03-19 Retrospective review of nicotine exposures in California from 2012 to 2018 and analysis of the impacts of e-cigarette regulations Driller, Gabrielle Plasencia, Emily Apollonio, Dorie E BMJ Open Smoking and Tobacco OBJECTIVES: To review the association between US e-cigarette regulations and the number of reported nicotine exposures, and identify higher-risk products DESIGN: Retrospective review of de-identified medical records. SETTING: California PARTICIPANTS: Cases reported to California Poison Control System in 2012–2018. PRIMARY AND SECONDARY OUTCOME MEASURES: Suspected nicotine toxicity; route of exposure and product characteristics. RESULTS: We examined 5277 exposures, of which 3033 involved combustible cigarettes, 1489 involved e-cigarettes and 818 involved other substances (ie, chewing tobacco, nicotine patches, nicotine lozenges, hookah, etc). Implementation of the Child Nicotine Poisoning Prevention Act of 2015 was not significantly associated with reduced exposures. Exposures for e-cigarettes increased significantly after the 2017 Food and Drug Administration Compliance Policy (p=0.003, coefficient (coeff)=0.61). Total exposures for all tobacco and nicotine products also increased significantly after the policy change (p=0.01, coeff=1.26). Nicotine exposure outcomes classified as being of minor and moderate severity increased significantly after implementation of the 2017 Compliance Policy (p=0.004, coeff=0.54 and p=0.002, coeff=0.56, respectively). Ingestion was the most common route of exposure (87.7%), followed by inhalation (8.1%), dermal (6.5%), ocular (2.1%) and other (intranasal, rectal, sublingual and unknown) routes (0.2%); some cases reported multiple routes of exposure. Exposure cases involving e-cigarettes fell into three problem categories: product design, labelling and the appeal of flavours. CONCLUSIONS: Our analysis found that despite previous studies suggesting that the Child Nicotine Poisoning Prevention Act appeared to have reduced exposures for e-cigarettes, there was no significant change in exposures after its implementation. In contrast, there was a 30% increase in California e-cigarette exposures following the 2017 Compliance Policy. We conclude that current regulations are insufficient to reduce nicotine toxicities due to e-cigarette use. BMJ Publishing Group 2021-03-02 /pmc/articles/PMC7929887/ /pubmed/33653751 http://dx.doi.org/10.1136/bmjopen-2020-043133 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Smoking and Tobacco
Driller, Gabrielle
Plasencia, Emily
Apollonio, Dorie E
Retrospective review of nicotine exposures in California from 2012 to 2018 and analysis of the impacts of e-cigarette regulations
title Retrospective review of nicotine exposures in California from 2012 to 2018 and analysis of the impacts of e-cigarette regulations
title_full Retrospective review of nicotine exposures in California from 2012 to 2018 and analysis of the impacts of e-cigarette regulations
title_fullStr Retrospective review of nicotine exposures in California from 2012 to 2018 and analysis of the impacts of e-cigarette regulations
title_full_unstemmed Retrospective review of nicotine exposures in California from 2012 to 2018 and analysis of the impacts of e-cigarette regulations
title_short Retrospective review of nicotine exposures in California from 2012 to 2018 and analysis of the impacts of e-cigarette regulations
title_sort retrospective review of nicotine exposures in california from 2012 to 2018 and analysis of the impacts of e-cigarette regulations
topic Smoking and Tobacco
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929887/
https://www.ncbi.nlm.nih.gov/pubmed/33653751
http://dx.doi.org/10.1136/bmjopen-2020-043133
work_keys_str_mv AT drillergabrielle retrospectivereviewofnicotineexposuresincaliforniafrom2012to2018andanalysisoftheimpactsofecigaretteregulations
AT plasenciaemily retrospectivereviewofnicotineexposuresincaliforniafrom2012to2018andanalysisoftheimpactsofecigaretteregulations
AT apolloniodoriee retrospectivereviewofnicotineexposuresincaliforniafrom2012to2018andanalysisoftheimpactsofecigaretteregulations